Pharmaceuticals on China's national reimbursement drug list

Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.

This statistic shows the number of pharmaceuticals that were on China's national reimbursement drug list in 2009 (a list that forms the basis of China's basic medical insurance coverage), sorted by pharmaceutical and list type. There were 154 types of traditional Chinese medicine pharmaceuticals on the NRDL's A list in 2009.

Number of pharmaceuticals on China's national reimbursement drug list in 2009, by type and list allocation*

Characteristic	Traditional Chinese Medicine	Western Drugs
-	-	-
-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

May 2011

More information

Region

China

Survey time period

2009

Supplementary notes

* The National Reimbursement Drug List (NRDL) provides the reimbursement framework for the 'urban employee basic medical insurance (BMI) scheme' and 'urban resident BMI scheme'.
** A List: Generic, low-cost products, fully reimbursable; decided by central government.
*** B list: Name brand products, generally higher in price. Compound drugs not listed in the NRDL, but made up by NRDL-listed drugs are reimbursable as List B drugs as long as the compound's price is not higher than the sum of its ingredient drugs.

Citation formats